CLOSE X
Company Profile
more from company profile
HomeMarkets Company Profile Financial Ratios

Financial Ratios

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE136.30-0.35 (-0.26 %)
PREV CLOSE ( ) 136.65
OPEN PRICE ( ) 136.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 122583
TODAY'S LOW / HIGH ( )134.55 137.50
52 WK LOW / HIGH ( )109.2 240.95
NSE136.42-0.42 (-0.31 %)
PREV CLOSE( ) 136.84
OPEN PRICE ( ) 136.06
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 136.42 (32)
VOLUME 853737
TODAY'S LOW / HIGH( ) 134.55 137.46
52 WK LOW / HIGH ( )109.3 241
Select year
Particulars
Mar 2025
Mar 2024
Mar 2023
Operational & Financial Ratios
 
 
 
   Earnings Per Share (Rs)
-10.55  
-11.93  
-6.86  
   CEPS(Rs)
-10.17  
-11.55  
-6.50  
   DPS(Rs)
0.00  
0.00  
0.00  
   Book NAV/Share(Rs)
-6.68  
3.88  
15.80  
   Tax Rate(%)
0.08  
-0.10  
0.00  
Margin Ratios
 
 
 
   Core EBITDA Margin(%)
-450.27  
-532.26  
-89.65  
   EBIT Margin(%)
-465.04  
-509.81  
-90.02  
   Pre Tax Margin(%)
-477.64  
-512.05  
-93.22  
   PAT Margin (%)
-477.26  
-512.56  
-93.22  
   Cash Profit Margin (%)
-459.99  
-496.00  
-88.29  
Performance Ratios
 
 
 
   ROA(%)
-80.88  
-57.63  
-26.81  
   ROE(%)
0.00  
-121.28  
-43.41  
   ROCE(%)
-311.92  
-112.35  
-41.91  
   Asset Turnover(x)
0.17  
0.11  
0.29  
   Sales/Fixed Asset(x)
0.46  
0.50  
1.63  
   Working Capital/Sales(x)
-0.21  
17.46  
0.87  
Efficiency Ratios
 
 
 
   Fixed Capital/Sales(x)
2.20  
2.01  
0.61  
   Receivable days
80.33  
116.55  
50.01  
   Inventory Days
0.00  
0.00  
0.00  
   Payable days
  
  
  
Valuation Parameters
 
 
 
   PER(x)
0.00  
0.00  
0.00  
   PCE(x)
-14.55  
-32.04  
-27.62  
   Price/Book(x)
-22.14  
95.47  
11.36  
   Yield(%)
0.00  
0.00  
0.00  
   EV/Net Sales(x)
70.50  
157.49  
23.92  
   EV/Core EBITDA(x)
-15.74  
-31.93  
-28.11  
   EV/EBIT(x)
-15.16  
-30.89  
-26.57  
   EV/CE(x)
122.69  
68.87  
11.14  
   M Cap / Sales
66.93  
158.92  
24.39  
Growth Ratio
 
 
 
   Net Sales Growth(%)
-5.00  
-68.36  
0.00  
   Core EBITDA Growth(%)
13.76  
-83.40  
0.00  
   EBIT Growth(%)
13.34  
-79.18  
0.00  
   PAT Growth(%)
11.55  
-73.96  
0.00  
   EPS Growth(%)
11.55  
-73.96  
0.00  
Financial Stability Ratios
 
 
 
   Total Debt/Equity(x)
-1.19  
0.37  
0.00  
   Current Ratio(x)
0.07  
1.02  
2.54  
   Quick Ratio(x)
0.07  
1.02  
2.54  
   Interest Cover(x)
-36.92  
-227.27  
-28.15  
   Total Debt/Mcap(x)
0.05  
0.00  
0.00  
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.